Poseida Therapeutics Ownership | Who Owns Poseida Therapeutics?
Poseida Therapeutics Ownership Summary
Poseida Therapeutics is owned by 55.06% institutional investors, 27.64% insiders, and 17.29% retail investors. Fmr is the largest institutional shareholder, holding 15.15% of PSTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.57% of its assets in Poseida Therapeutics shares.
PSTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Poseida Therapeutics | 55.06% | 27.64% | 17.29% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 14.54M | 15.15% | $42.47M |
| Pentwater capital management lp | 5.97M | 6.22% | $17.45M |
| Blackrock | 4.91M | 5.11% | $14.32M |
| Boxer capital | 4.47M | 4.66% | $13.07M |
| Silverarc capital management | 3.61M | 3.76% | $10.54M |
| Vanguard group | 3.41M | 3.55% | $9.94M |
| State street | 1.67M | 1.74% | $4.88M |
| Geode capital management | 1.62M | 1.69% | $4.74M |
| Blair william & co/il | 1.10M | 1.15% | $3.22M |
| Aisling capital management lp | 1.04M | 1.09% | $3.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Silverarc capital management | 3.61M | 2.49% | $10.54M |
| Aisling capital management lp | 1.04M | 1.32% | $3.05M |
| Boxer capital | 4.47M | 0.69% | $13.07M |
| Pentwater capital management lp | 5.97M | 0.22% | $17.45M |
| Mcf advisors | 247.02K | 0.05% | $721.31K |
| Forefront analytics | 29.82K | 0.04% | $87.06K |
| Cornercap investment counsel | 79.22K | 0.04% | $231.33K |
| Xtx topco | 124.30K | 0.03% | $362.96K |
| Callan capital | 84.08K | 0.02% | $245.51K |
| Keystone financial group | 15.00K | 0.02% | $43.80K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 854.90K | 0.00% | 297.50K |
| State street | 1.67M | 0.00% | 220.81K |
| Mirae asset global etfs | 173.11K | 0.00% | 173.11K |
| Blair william & co/il | 1.10M | 0.01% | 136.27K |
| Nuveen asset management | 402.88K | 0.00% | 130.69K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -736.00K |
| Atom investors lp | - | - | -395.77K |
| Connor, clark & lunn investment management | 220.69K | 0.00% | -283.07K |
| Jane street group | 109.09K | 0.00% | -220.83K |
| Morgan stanley | 363.28K | 0.00% | -105.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Mirae asset global etfs | 173.11K | 0.00% | 173.11K | $505.49K |
| Squarepoint ops | 82.64K | 0.00% | 82.64K | $241.30K |
| Corebridge financial | 36.94K | 0.00% | 36.94K | $107.85K |
| Marshall wace, llp | 10.54K | - | 10.54K | $30.77K |
| Cwm | 233.00 | - | 233.00 | $1.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Nverses capital | -800.00 |
| Metropolitan life insurance co/ny | -1.82K |
| Us bancorp \de\ | -5.20K |
| Central bank & trust | -7.61K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 97 | 3.19% | 53,501,171 | 1.05% | 55 | 1.81% | 53 | - | 21 | - |
| Jun 30, 2024 | 94 | 1.08% | 52,945,375 | 0.40% | 55 | 1.61% | 53 | 6.00% | 21 | -8.70% |
| Mar 31, 2024 | 93 | 3.33% | 52,736,698 | 16.63% | 58 | 2.42% | 50 | 4.17% | 23 | -4.17% |
| Dec 31, 2023 | 90 | 2.27% | 45,216,197 | 0.03% | 49 | 1.81% | 48 | 17.07% | 24 | 9.09% |
| Sep 30, 2023 | 88 | -7.37% | 45,201,367 | 1.58% | 52 | 1.96% | 41 | -33.87% | 22 | 37.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.44M | 4.57% | 29.37K |
| Fidelity Growth Compy Commingled Pl O | 4.41M | 4.54% | 12.03K |
| Fidelity Growth Company Fund | 3.48M | 3.59% | -7.40K |
| Fidelity Select Health Care | 2.39M | 2.46% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.14M | 2.20% | - |
| iShares Russell 2000 ETF | 1.71M | 1.76% | -3.84K |
| Fidelity Advisor Health Care I | 1.45M | 1.50% | - |
| Fidelity Growth Company K6 | 1.27M | 1.31% | -21.98K |
| Vanguard Institutional Extnd Mkt Idx Tr | 993.34K | 1.02% | - |
| Fidelity Series Growth Company | 937.36K | 0.96% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Gergen Mark J | Executive Chairman | Sell | $283.87K |
| Nov 26, 2024 | Gergen Mark J | Executive Chairman | Sell | $278.10K |
| Aug 08, 2022 | Malin Life Sciences Holdings Ltd | Buy | $7.53M | |
| Aug 08, 2022 | Ostertag Eric | Executive Chairman | Buy | $500.00K |
| Aug 03, 2022 | Ostertag Eric | Executive Chairman | Sell | $592.81K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 2 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
PSTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools